Articles dans des revues avec comité de lecture (27)
  1. 1. Otmani, K., Rouas, R., Berehab, M., & Lewalle, P. (2024). The regulatory mechanisms of oncomiRs in cancer. Biomedicine & pharmacotherapy, 171, 116165. doi:10.1016/j.biopha.2024.116165
  2. 2. Otmani, K., Rouas, R., Lagneaux, L., Krayem, M., Duvillier, H., Berehab, M., & Lewalle, P. (2023). Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways. Cell Communication and Signaling, 21(1), 253. doi:10.1186/s12964-023-01259-1
  3. 3. Otmani, K., Rouas, R., & Lewalle, P. (2022). OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications. Frontiers in immunology, 13, 913951. doi:10.3389/fimmu.2022.913951
  4. 4. Berehab, M., Rouas, R., Akl, H., Duvillier, H., Journé, F., Fayyad Kazan, H., Ghanem, G. E., Bron, D., Lewalle, P., & Merimi, M. (2021). Apoptotic and non-apoptotic modalities of thymoquinone-induced lymphoma cell death: Highlight of the role of cytosolic calcium and necroptosis. Cancers (Basel), 13(14), 3579. doi:10.3390/cancers13143579
  5. 5. Cogels, M., Rouas, R., Ghanem, G. E., Martinive, P., Awada, A., Van Gestel, D., & Krayem, M. (2021). Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research. Frontiers in oncology, 11, 784947. doi:10.3389/fonc.2021.784947
  6. 6. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Fayyad Kazan, H., Lagneaux, L., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction. Cells, 9(9). doi:10.3390/cells9092053
  7. 7. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Naamane, N., Fayyad Kazan, H., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs. International journal of molecular sciences, 21(19). doi:10.3390/ijms21197065
  8. 8. Rouas, R., Merimi, M., Najar, M., El Zein, N., Fayyad Kazan, M., Berehab, M., Moussa Agha, D., Bron, D., Burny, A., Rachidi, W., Badran, B., Lewalle, P., & Fayyad Kazan, H. (2019). Human CD8 + CD25 + CD127 low regulatory T cells: microRNA signature and impact on TGF‐β and IL‐10 expression. Journal of cellular physiology. doi:10.1002/jcp.28367
  9. 9. Rouas, R., Merimi, M., Najar, M., Zein, N. E., Fayyad Kazan, M., Berehab, M., Moussa Agha, D., Bron, D., Burny, A., Rachidi, W., Badran, B., Lewalle, P., & Fayyad Kazan, H. (2019). Human CD8+ CD25 + CD127 low regulatory T cells: microRNA signature and impact on TGF-β and IL-10 expression. Journal of cellular physiology. doi:10.1002/jcp.28367
  10. 10. Al-Akoum, C., Badran, B., Akl, I., Rouas, R., Fayyad Kazan, M., Falha, L., Renno, T., Burny, A., Lewalle, P., & Fayyad Kazan, H. (2015). NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cells. Human immunology, 76(5), 307-317. doi:10.1016/j.humimm.2015.03.010
  11. 11. Jebbawi, F., Fayyad Kazan, H., Merimi, M., Lewalle, P., Verougstraete, J. C., Leo, O., Romero, P., Burny, A., Badran, B., Martiat, P., & Rouas, R. (2014). A microRNA profile of human CD8+ regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes. Journal of translational medicine, 12(1), 218. doi:10.1186/s12967-014-0218-x
  12. 12. Fayyad Kazan, H., Rouas, R., Burny, A., Martiat, P., Hamade, E., El Zein, N., ElDirani, R., Hussein, N., Fakhry, M., Al-Akoum, C., Badran, B., Najar, M., & Fayyad Kazan, M. (2014). Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-γ secreted by activated human CD4 lymphocytes. Human immunology, 75(7), 677-685. doi:10.1016/j.humimm.2014.01.007
    13. << Précédent 1 2 3 Suivant >>